about
Ocriplasmin: who is the best candidate?PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesionProteomic Analysis of Embryonic and Young Human VitreousEnzymatic degradation identifies components responsible for the structural properties of the vitreous bodyParadigm Shifts in Ophthalmic Diagnostics.Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential.Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a reviewEnzymatic vitrectomy for diabetic retinopathy and diabetic macular edema.Evisceration of mouse vitreous and retina for proteomic analyses.Translational vitreous proteomics.Dissection of human vitreous body elements for proteomic analysis.Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.The vitreomacular interface in different types of age-related macular degeneration.Effect of short-term enzymatic treatment on cell migration and cartilage regeneration: in vitro organ culture of bovine articular cartilage.Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.Assessment of Ocriplasmin Effects on the Vitreoretinal Compartment in Porcine and Human Model Systems.Floaters and reduced contrast sensitivity after successful pharmacologic vitreolysis with ocriplasmin.
P2860
Q28078808-6A882D76-D826-4EF7-B5D4-FDA76596BFB5Q30490717-BD56B958-8C91-49CE-B91F-575FC83D67A2Q33599492-3C2A76C7-6888-4BA9-9B4D-8D85133128B3Q37415486-DEABD6B2-357D-4E2A-A223-F0CE69D34D1DQ37442833-784EA063-6BAB-4616-8D55-F9FD5B1F084EQ37480451-647D084D-5AA3-4A32-922A-F7D9849C0EE5Q37669379-14B6EF4F-B28A-4338-BBC5-552C8CC5878DQ37925601-34A597D8-B531-403D-BD53-EA85EC8A6A2FQ38174893-6A80CFDA-D435-4600-B2DA-0B1B0C1299EDQ38352959-D371CC91-1F6E-49E8-B403-28BA49BCEA5BQ38454698-39F5C420-313F-4013-87FA-A73606B2B99DQ38588426-50B547D3-9C8E-4D55-BD78-C0ECDC4257B1Q39960008-F062E9EE-62E0-44E6-8672-83EFA716BB52Q42132169-AF75AE77-679B-4F57-ADA4-96B1FF841EC8Q42725411-4257FCB8-D0C1-44D5-9AC8-538429E868E0Q43104744-0E3EA44C-8E43-48E5-B714-DD340CEF1003Q45331770-FF1D50AF-37BA-42D6-964D-1B6D58D60986Q53578647-D701AC1D-5EB6-477B-8528-03504EB8E609
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular biology of pharmacologic vitreolysis.
@ast
Molecular biology of pharmacologic vitreolysis.
@en
Molecular biology of pharmacologic vitreolysis.
@nl
type
label
Molecular biology of pharmacologic vitreolysis.
@ast
Molecular biology of pharmacologic vitreolysis.
@en
Molecular biology of pharmacologic vitreolysis.
@nl
prefLabel
Molecular biology of pharmacologic vitreolysis.
@ast
Molecular biology of pharmacologic vitreolysis.
@en
Molecular biology of pharmacologic vitreolysis.
@nl
P2860
P1476
Molecular biology of pharmacologic vitreolysis
@en
P2093
P2860
P304
P577
2005-01-01T00:00:00Z